Do GLP-1 drugs cause blood clots? What the evidence shows

Do GLP-1 drugs cause blood clots?

Blood clots are not an established side effect of GLP-1 receptor agonists. They are not commonly listed on the labels of tirzepatide (Mounjaro, Zepbound) or semaglutide (Ozempic, Wegovy), and there is no clear evidence that these drugs cause deep vein thrombosis (a clot, usually in a leg) or pulmonary embolism (a clot that travels to the lungs). If you have seen this question a lot, it is largely because clots are a serious, frightening topic and people reasonably want to rule the medication in or out.

What the evidence actually points to

The picture from large trials leans the other way, toward cardiovascular benefit. Semaglutide's major outcome trial, SELECT, followed more than 17,000 people and found a reduction in cardiovascular events. Tirzepatide has strong metabolic effects and its own outcome research. Losing excess weight and improving blood sugar and blood pressure generally lowers cardiovascular risk over time. None of this proves these drugs prevent clots, but it is the opposite of a signal that they cause them.

Why a clot could still happen (and it may have nothing to do with the drug)

Clots have well-known risk factors that exist independently of any GLP-1: long periods of immobility (a long flight, surgery, bed rest), a personal or family history of clots, certain clotting disorders, some hormonal contraception and hormone therapy, smoking, cancer, and pregnancy. Rapid weight loss itself is not a recognized clot cause, but if you have surgery during weight loss, the usual surgical clot precautions apply. So a clot on a GLP-1 is far more likely to be about these factors than the medication.

Know the warning signs

Because clots are serious, everyone should recognize the signs, whatever medication they take:

• Deep vein thrombosis (leg clot): swelling, pain, warmth, or redness usually in one leg or calf.
• Pulmonary embolism (lung clot), a medical emergency: sudden shortness of breath, sharp chest pain that worsens with breathing, coughing (sometimes with blood), a racing heart, or feeling faint.

Pulmonary embolism symptoms need emergency care immediately. A suspected leg clot needs urgent same-day assessment.

The practical takeaway

There is no established link between GLP-1 drugs and blood clots, and the cardiovascular data is reassuring. If you have a personal or family history of clots or a clotting disorder, tell your prescriber so your overall risk is considered. Our Ozempic safety post and GLP-1 benefits post put the cardiovascular picture in context, and the pre-surgery post covers clot precautions around operations. This article is general information, not medical advice.